China's political advisers are encouraging domestic generic drug development--but at the same time, they're also pushing for tougher quality standards. Thursday, a top advisory body suggested cutting some of the red tape associated with drugmaking. Doing so shouldn't come at the expense of quality, though, it cautioned. "Improving the quality of generic drugs concerns the sustainability of the health insurance system and matters to whether people can afford efficient drugs," it said in a statement seen by local news outlet Xinhua. More from FiercePharmaAsia